HIV-1 diversity and the implementation of integrase strand-transfer inhibitors as part of combination antiretroviral therapy

Mikasi, S.G.Ikomey, G.M.Obasa, A.E.Cloete, R.Jacobs, G.B.2024-01-032024-01-032020-08-31Mikasi SG, Ikomey GM, Obasa AE, Cloete R, Jacobs GB. HIV-1 diversity and the implementation of integrase strand-transfer inhibitors as part of combination antiretroviral therapy. S Afr Med J. 2020 Aug 31;110(9):13071. doi:10.7196/SAMJ.2020.v110i9.14848.0256-957410.7196/SAMJ.2020.v110i9.14848http://www.samj.org.za/index.php/samj/article/view/13071https://infospace.mrc.ac.za/handle/11288/595327enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/HIVIntegraseDiversityResistanceHIV-1 diversity and the implementation of integrase strand-transfer inhibitors as part of combination antiretroviral therapyArticleSouth African Medical Journal